Centessa Pharmaceuticals (CNTA)
(Real Time Quote from BATS)
$11.50 USD
+0.49 (4.45%)
Updated Aug 14, 2024 09:36 AM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | -5.26% |
ABR | 1.29 |
Earnings ESP
|
5.88% |
---|---|
Current Year | -1.62 |
Next Year | -1.60 |
EPS (TTM) | -1.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 6.85M | 6.85M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.48 | -1.62 | -1.60 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.41 | -0.42 | -1.68 | -1.78 |
High Estimate | -0.34 | -0.37 | -1.48 | -1.45 |
Low Estimate | -0.42 | -0.66 | -1.71 | -1.78 |
Year ago EPS | -0.40 | -0.38 | -1.57 | -1.62 |
Year over Year Growth Est. | 5.00% | -26.32% | -3.18% | 1.23% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.48 | -1.62 | -1.60 |
7 Days Ago | -0.38 | -0.48 | -1.62 | -1.60 |
30 Days Ago | -0.39 | -0.51 | -1.67 | -1.61 |
60 Days Ago | -0.40 | -0.54 | -1.71 | -1.61 |
90 Days Ago | -0.44 | -0.48 | -1.76 | -1.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.37 | -1.48 | -1.57 |
Zacks Consensus Estimate | -0.38 | -0.48 | -1.62 | -1.60 |
Earnings ESP | 5.88% | 22.11% | 8.78% | 2.03% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.38 | -0.38 | -0.40 | NA |
Estimate | -0.38 | -0.41 | -0.44 | -0.46 | NA |
Difference | -0.02 | 0.03 | 0.06 | 0.06 | 0.03 |
Surprise | -5.26% | 7.32% | 13.64% | 13.04% | 7.19% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more